Open | - |
Close | - |
Volume / Avg. | 23.938K / 1.512M |
Day Range | - - - |
52 Wk Range | 11.090 - 18.220 |
Market Cap | $1.896B |
P/E Ratio | 25.524 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 5.94% |
Days to Cover | 5.09 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Catalyst Pharmaceuticals (NASDAQ: CPRX) through any online brokerage.
Other companies in Catalyst Pharmaceuticals’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Syndax Pharmaceuticals (NASDAQ:SNDX), PTC Therapeutics (NASDAQ:PTCT) and Protagonist Therapeutics (NASDAQ:PTGX).
The latest price target for Catalyst Pharmaceuticals (NASDAQ: CPRX) was reported by Cantor Fitzgerald on Thursday, March 14, 2024. The analyst firm set a price target for 34.00 expecting CPRX to rise to within 12 months (a possible 111.31% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Catalyst Pharmaceuticals (NASDAQ: CPRX) is $16.09 last updated Today at March 19, 2024 at 9:33 AM EDT.
There are no upcoming dividends for Catalyst Pharmaceuticals.
Catalyst Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Catalyst Pharmaceuticals.
Catalyst Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.